Guggenheim Capital’s Neurocrine Biosciences NBIX Stock Holding History

Guggenheim Capital’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.12M	Buy	38,866 +14,823	+62%	+$1.97M	0.04%	441
2025 Q4	$3.41M	Buy	24,043 +1,755	+8%	+$254K	0.03%	533
2025 Q3	$3.13M	Sell	22,288 -636	-3%	-$86.2K	0.02%	564
2025 Q2	$2.88M	Sell	22,924 -1,355	-6%	-$155K	0.02%	550
2025 Q1	$2.69M	Buy	24,279 +1,381	+6%	+$175K	0.03%	563
2024 Q4	$3.13M	Sell	22,898 -9,134	-29%	-$1.13M	0.03%	532
2024 Q3	$3.69M	Sell	32,032 -18,115	-36%	-$2.48M	0.03%	626
2024 Q2	$6.9M	Buy	50,147 +12,629	+34%	+$1.73M	0.05%	420
2024 Q1	$5.17M	Buy	37,518 +8,579	+30%	+$1.17M	0.04%	543
2023 Q4	$3.81M	Sell	28,939 -10,169	-26%	-$1.17M	0.03%	617
2023 Q3	$4.4M	Sell	39,108 -5,188	-12%	-$546K	0.04%	531
2023 Q2	$4.18M	Buy	44,296 +2,415	+6%	+$236K	0.03%	587
2023 Q1	$4.24M	Sell	41,881 -265	-0.6%	-$27.6K	0.04%	576
2022 Q4	$5.03M	Sell	42,146 -1,351	-3%	-$158K	0.04%	523
2022 Q3	$4.62M	Sell	43,497 -3,782	-8%	-$384K	0.04%	531
2022 Q2	$4.61M	Sell	47,279 -10,003	-17%	-$923K	0.04%	578
2022 Q1	$5.37M	Sell	57,282 -4,900	-8%	-$415K	0.03%	622
2021 Q4	$5.3M	Buy	62,182 +3,449	+6%	+$317K	0.03%	663
2021 Q3	$5.63M	Sell	58,733 -1,322	-2%	-$125K	0.03%	612
2021 Q2	$5.84M	Buy	60,055 +9,106	+18%	+$873K	0.03%	615
2021 Q1	$4.96M	Buy	50,949 +12,056	+31%	+$1.26M	0.03%	631
2020 Q4	$3.73M	Buy	38,893 +352	+0.9%	+$34K	0.02%	714
2020 Q3	$3.71M	Sell	38,541 -5,981	-13%	-$692K	0.03%	647
2020 Q2	$5.43M	Buy	44,522 +4,185	+10%	+$462K	0.04%	489
2020 Q1	$3.49M	Sell	40,337 -8,860	-18%	-$867K	0.04%	587
2019 Q4	$5.29M	Buy	49,197 +7,896	+19%	+$827K	0.04%	604
2019 Q3	$3.72M	Sell	41,301 -8,776	-18%	-$820K	0.03%	746
2019 Q2	$4.23M	Sell	50,077 -6,910	-12%	-$567K	0.03%	695
2019 Q1	$5.02M	Buy	56,987 +404	+0.7%	+$33.8K	0.04%	611
2018 Q4	$4.04M	Buy	56,583 +5,190	+10%	+$497K	0.04%	675
2018 Q3	$6.32M	Sell	51,393 -4,330	-8%	-$491K	0.04%	594
2018 Q2	$5.47M	Sell	55,723 -2,592	-4%	-$232K	0.04%	660
2018 Q1	$4.84M	Sell	58,315 -7,540	-11%	-$637K	0.01%	1034
2017 Q4	$5.11M	Sell	65,855 -26,490	-29%	-$1.81M	0.01%	1029
2017 Q3	$5.66M	Sell	92,345 -4,140	-4%	-$218K	0.01%	990
2017 Q2	$4.44M	Buy	96,485 +7,720	+9%	+$374K	0.01%	1090
2017 Q1	$3.84M	Buy	88,765 +6,620	+8%	+$284K	0.01%	1184
2016 Q4	$3.18M	Sell	82,145 -6,420	-7%	-$291K	0.01%	1304
2016 Q3	$4.49M	Sell	88,565 -10,442	-11%	-$520K	0.01%	1078
2016 Q2	$4.5M	Sell	99,007 -17,365	-15%	-$799K	0.01%	1056
2016 Q1	$4.6M	Sell	116,372 -29,123	-20%	-$1.16M	0.01%	1032
2015 Q4	$8.23M	Sell	145,495 -48,205	-25%	-$2.45M	0.02%	820
2015 Q3	$7.71M	Sell	193,700 -37,622	-16%	-$1.82M	0.02%	853
2015 Q2	$11M	Buy	231,322 +12,960	+6%	+$550K	0.03%	792
2015 Q1	$8.67M	Buy	218,362 +16,145	+8%	+$578K	0.02%	915
2014 Q4	$4.52M	Buy	202,217 +8,032	+4%	+$152K	0.01%	1171
2014 Q3	$3.04M	Buy	194,185 +4,458	+2%	+$66.6K	0.01%	1477
2014 Q2	$2.82M	Sell	189,727 -36,403	-16%	-$514K	0.01%	1532
2014 Q1	$3.64M	Sell	226,130 -27,244	-11%	-$466K	0.01%	1325
2013 Q4	$2.37M	Sell	253,374 -4,218	-2%	-$41.2K	0.01%	1628
2013 Q3	$2.92M	Buy	+257,592	New	+$3.54M	0.01%	1370